* Note: Prices are in Million (M) USD.
Description:
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $73 M
Debt : $2,846 M
EBITDA : $249 M
Net Debt (Debt - Cash): $2,772 M
Since EBITDA cannot cover net debt within 3 years, Avoid This Stock.
This criteria used industry in which company operates:
Sector: Health Care
Industry: Medical Care Facilities
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 9.20
Since Forward PE Ratio is less than 15, 5 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $7 M
Average Revenue: $2,233 M
Revenue Converted To Free Cash Flow (%): 0%
Avg Free Cash Flow Growth Per Year (Last 2 Years): 65.30%
Since Free Cash Flow (FCF) to Revenue percentage is less than 15, 1 point assigned.
This criteria used company's growth potential to calculate its fair value:
Error: This stock does not have 5 years of revenue data.Using default values for calculation.
Based on default values, 1 points assigned.
This criteria used Company's ability to buy back its own share:
Error: This stock does not have 5 years of share count data.Using default values for calculation.
Based on default values, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $1.98
Trailing 12-Month Earnings Per Share (EPS): $0.64
Average Earnings Per Share (EPS): $1.31
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%
Since Dividend Per Share is less than or equal to 0, 0 point assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: 177%
Since Average ROE is greater than 20, 5 points assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $12
52-Week Low: $8
Threshold Price (15% Above 52-Week Low): $10
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $1,741 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 2% exposure of Total Portfolio.
Value-Trade has assigned 15 points to above PACS Group, Inc. (PACS) stock.
Last 1 Years Avg PE 15.99, Fair Value PE 12, Industry Based PE 15, RCFC Based PE 0.3. Based on these 4 values, average assigned is 10.82.
Value-Trades has assined P/E value 10.82. Since an average (Current Year EPS + Next Year EPS) earning per share is $1.31.
The fair value of PACS Group, Inc. (PACS) stock should be (10.82 x $1.31) = $14.17
